E J Meuleman

793 total citations
20 papers, 598 citations indexed

About

E J Meuleman is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Urology. According to data from OpenAlex, E J Meuleman has authored 20 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Urology. Recurrent topics in E J Meuleman's work include Sexual function and dysfunction studies (13 papers), Hormonal and reproductive studies (6 papers) and Sexual Differentiation and Disorders (3 papers). E J Meuleman is often cited by papers focused on Sexual function and dysfunction studies (13 papers), Hormonal and reproductive studies (6 papers) and Sexual Differentiation and Disorders (3 papers). E J Meuleman collaborates with scholars based in Netherlands, United States and Germany. E J Meuleman's co-authors include D.D.M. Braat, J.H.A.M. Tuerlings, Lies H. Hoefsloot, Jan A.M. Kremer, Hans M.W.M. Merkus, H. Porst, V Michal, Irène Buvat, Gorm Wagner and F. Schoute and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Urology and Human Reproduction.

In The Last Decade

E J Meuleman

19 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E J Meuleman Netherlands	11	361	284	139	123	110	20	598
A. Bertoldo Italy	4	236 0.7×	211 0.7×	113 0.8×	48 0.4×	145 1.3×	5	488
Nancy Phillips United States	11	156 0.4×	159 0.6×	46 0.3×	34 0.3×	67 0.6×	21	372
Yonah Krakowsky Canada	13	107 0.3×	248 0.9×	34 0.2×	59 0.5×	100 0.9×	48	607
Silvia Martella Italy	9	235 0.7×	230 0.8×	28 0.2×	41 0.3×	77 0.7×	17	451
Irene Scavello Italy	12	270 0.7×	187 0.7×	21 0.2×	70 0.6×	75 0.7×	21	413
H Ghanem Egypt	8	198 0.5×	59 0.2×	63 0.5×	76 0.6×	74 0.7×	21	312
E. W. Hauck Germany	10	190 0.5×	149 0.5×	92 0.7×	51 0.4×	78 0.7×	27	363
B. Gümüş Türkiye	9	163 0.5×	224 0.8×	73 0.5×	18 0.1×	108 1.0×	21	419
P D Kell United Kingdom	12	441 1.2×	350 1.2×	187 1.3×	112 0.9×	20 0.2×	29	678
Terry Payton United States	9	317 0.9×	227 0.8×	136 1.0×	77 0.6×	11 0.1×	14	390

Countries citing papers authored by E J Meuleman

Since Specialization

Citations

This map shows the geographic impact of E J Meuleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E J Meuleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E J Meuleman more than expected).

Fields of papers citing papers by E J Meuleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E J Meuleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E J Meuleman. The network helps show where E J Meuleman may publish in the future.

Co-authorship network of co-authors of E J Meuleman

This figure shows the co-authorship network connecting the top 25 collaborators of E J Meuleman. A scholar is included among the top collaborators of E J Meuleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E J Meuleman. E J Meuleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sturm, Patrick, et al.. (2006). Urosepsis with Actinobaculum schaalii and Aerococcusurinae. Journal of Clinical Microbiology. 44(2). 652–654. 41 indexed citations

Montorsi, Francesco, E J Meuleman, K.-P. Jünemann, et al.. (2003). Long-Term Safety and Tolerability of Tadalafil in the Treatment of Erectile Dysfunction. European Urology. 45(3). 339–345. 104 indexed citations

Rosen, Rachel, Michael P. O’Leary, Jens E. Altwein, et al.. (2003). Luts and male sexual dysfunction: The multi-national survey of the aging male (MSAM-7). European Urology Supplements. 2(1). 94–94. 16 indexed citations

Woldringh, G.H., et al.. (2003). [Obstructive azoospermia in men who wish to father children; initial clinical results of intracytoplasmatic sperm injection (ICSI) with surgically retrieved epididymal semen].. PubMed. 147(52). 2587–91. 1 indexed citations

Rosen, R., Margie O’Leary, J. E. Altwein, et al.. (2003). Ejaculatory disorders are frequent and bothersome in ageing males with luts: A worldwide survey (MSAM-7). European Urology Supplements. 2(1). 94–94. 7 indexed citations

Hilbrands, Luuk B., et al.. (2001). LOWER URINARY TRACT SYMPTOMS AFTER RENAL TRANSPLANTATION. The Journal of Urology. 1237–1241. 3 indexed citations

Meuleman, E J, B. Cuzin, Reinier Opsomer, et al.. (2001). A dose‐escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction. British Journal of Urology. 87(1). 75–81. 59 indexed citations

Bleumer, Ivar, et al.. (2001). The value of sildenafil as mode of stimulation in pharmaco-penile duplex ultrasonography. International Journal of Impotence Research. 13(4). 189–191. 15 indexed citations

Meuleman, E J, et al.. (2001). [Erectile dysfunction: prevalence and effect on the quality of life; Boxmeer study].. PubMed. 145(12). 576–81. 41 indexed citations

10.

Giuliano, F., et al.. (2000). Daily IC351 treatment of erectile dysfunction. 2. 80. 3 indexed citations

11.

Hartmann, Uwe, E J Meuleman, B. Cuzin, et al.. (1999). Sildenafil citrate (VIAGRA): analysis of preferred doses in a European, six-month, double-blind, placebo-controlled, flexible dose-escalation study in patients with erectile dysfunction. Multicentre Study Group.. PubMed. 102. 27–9. 5 indexed citations

12.

Porst, H., Irène Buvat, E J Meuleman, V Michal, & Gorm Wagner. (1998). Intracavernous Alprostadil Alfadex—an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study. International Journal of Impotence Research. 10(4). 225–231. 61 indexed citations

13.

Tuerlings, J.H.A.M., M J Ligtenberg, Jan A.M. Kremer, et al.. (1998). Screening male intracytoplasmic sperm injection candidates for mutations of the follicle stimulating hormone receptor gene. Human Reproduction. 13(8). 2098–2101. 23 indexed citations

14.

Kremer, Jan A.M., J.H.A.M. Tuerlings, E J Meuleman, et al.. (1997). Microdeletions of the Y chromosome and intracytoplasmic sperm injection: from gene to clinic. Human Reproduction. 12(4). 687–691. 99 indexed citations

15.

Meuleman, E J, et al.. (1997). [Infertility caused by ejaculation disturbances and anorgasmy].. PubMed. 141(23). 1141–4. 1 indexed citations

16.

Tuerlings, J.H.A.M., J.A.M. Kremer, & E J Meuleman. (1997). [Genetic investigation required in male infertility].. PubMed. 141(23). 1129–33. 2 indexed citations

17.

Bierkens, A.F., G.O.N. Oosterhof, E J Meuleman, & F.M.J. Debruyne. (1996). Anterograde PercutaneousTreatment of UreterointestinalStrictures following. European Urology. 30(3). 363–368. 24 indexed citations

18.

Meuleman, E J, et al.. (1996). The post-investigation questionnaire (PIO-R): a practical instrument to assess erectile response after intracavernous injection.. PubMed. 8(2). 59–62. 7 indexed citations

19.

Meuleman, E J, et al.. (1995). Investigation of erectile dysfunction. Diagnostic testing for vascular factors in erectile dysfunction.. PubMed. 22(4). 803–19. 78 indexed citations

20.

Meuleman, E J. (1993). [Experiences with a vacuum apparatus in the treatment of erection disorders].. PubMed. 137(8). 412–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact